Jump to content

Draft:TC-C 14G

From Wikipedia, the free encyclopedia
  • Comment: This article is very difficult to understand as it is written right now. Please fix its prose to make it more understandable to laypeople (or at least, those only with basic knowledge of biomolecules). Also, the majority of citations are devoted to the Synthesis section. More citations should be about its biological activity. Pygos (talk) 03:43, 5 December 2024 (UTC)

TC-C 14G
Identifiers
  • [2-(2,4-dichlorophenyl)-6-fluoro-2-(4-fluorophenyl)-1,3-benzodioxol-5-yl]-morpholin-4-ylmethanone
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC24H17Cl2F2NO4
Molar mass492.30 g·mol−1
3D model (JSmol)
  • C1COCCN1C(=O)C2=CC3=C(C=C2F)OC(O3)(C4=CC=C(C=C4)F)C5=C(C=C(C=C5)Cl)Cl
  • InChI=InChI=1S/C24H17Cl2F2NO4/c25-15-3-6-18(19(26)11-15)24(14-1-4-16(27)5-2-14)32-21-12-17(20(28)13-22(21)33-24)23(30)29-7-9-31-10-8-29/h1-6,11-13H,7-10H2
  • Key:VUCKSZWMRCSPME-UHFFFAOYSA-N

TC-C 14G is a potent, high affinity inverse agonist of the CB1 receptor: (EC50 = 11 nM in cAMP assay; Ki = 4 nM). Demonstrates high efficacy in a hypothermia assay (ID50 = 5 mg/kg) in vivo.[1]

Similar to rimonabant (and related agents such as giminabant), TC-C 14G potentially might have use in the treatment of obesity.

Synthesis

[edit]

Literature report:[2] Patent (Ex 108):[3] Prec:[4]

TC-C 14G synthesis
TC-C 14G synthesis
  • 4-fluoroveratrole [398-62-9] (1)
  • 4-bromo-5-fluoro-benzene-1,2-diol [656804-73-8] (2)
  • 2,4-dichlorobenzotrifluoride [320-60-5] (3)
  • Fluorobenzene [462-06-6] (4)
  • 2,4-dichloro-4'-fluoro-diphenyldichloromethane [656803-77-9] (5)
  • 5-bromo-2-(2,4-dichloro-phenyl)-6-fluoro-2-(4-fluoro-phenyl)-benzo[1,3]dioxole, PC22475200 (6)
  • PC22475029 (7)

References

[edit]
  1. ^ "tc-c-14g_4345". Trocris.
  2. ^ Alig L, Alsenz J, Andjelkovic M, Bendels S, Bénardeau A, Bleicher K, et al. (April 2008). "Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity". Journal of Medicinal Chemistry. 51 (7): 2115–27. doi:10.1021/jm701487t. PMID 18335976.
  3. ^ WO 2004013120, Alanine A, Beleicher K, Guba W, Haap w, Kuber D, Luebbers T, Plancher JM, Rogers-Evans M, Schneider G, Zuegge J, Roche O, "Novel benzodioxoles", assigned to Hoffmann La Roche Inc. 
  4. ^ Furlano DC, Kirk KL (October 1986). "An improved synthesis of 4-fluoroveratrole. Efficient route to 6-fluoroveratraldehyde and 6-fluoro-D, L-DOPA". The Journal of Organic Chemistry. 51 (21): 4073–4075. doi:10.1021/jo00371a032.